GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anika Therapeutics Inc (FRA:AKP) » Definitions » Accumulated other comprehensive income (loss)

Anika Therapeutics (FRA:AKP) Accumulated other comprehensive income (loss) : €-5.8 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Anika Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Anika Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-5.8 Mil.

Anika Therapeutics's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (€-6.2 Mil) to Dec. 2023 (€-5.5 Mil) but then declined from Dec. 2023 (€-5.5 Mil) to Mar. 2024 (€-5.8 Mil).

Anika Therapeutics's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-5.1 Mil) to Dec. 2022 (€-6.1 Mil) but then increased from Dec. 2022 (€-6.1 Mil) to Dec. 2023 (€-5.5 Mil).

Anika Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Anika Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anika Therapeutics Accumulated other comprehensive income (loss) Chart

Anika Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.31 -3.73 -5.06 -6.08 -5.45

Anika Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.76 -5.68 -6.15 -5.45 -5.81

Anika Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Anika Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Anika Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Anika Therapeutics (FRA:AKP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anika Therapeutics Inc (FRA:AKP) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
OSUR ZJYL SMTI ANGO UTMD STXS INFU HBIO YBGJ PLSE ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD OCSE:COLO B TSE:4543 WST XSWX:STMN
Traded in Other Exchanges
ANIK:USA
Address
32 Wiggins Avenue, Bedford, MA, USA, 01730
Website
https://www.anika.com
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.